1. Optimal Management of Patients with Advanced NSCLC Harboring High PD-L1 Expression and Driver Mutations

   • Justin A. Chen
   • Jonathan W. Riess

   Lung Cancer (HA Wakelee and TA Leal, Section Editors) 25 June 2020 Article: 60

2. Clinical Development of PD-1/PD-L1 Inhibitors in Breast Cancer: Still a Long Way to Go

   • Romualdo Barroso-Sousa
   • Sara M. Tolaney

   Breast Cancer (WJ Gradishar, Section Editor) 17 June 2020 Article: 59

3. Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives?

   • Tina W. Zhang
   • David Palma
   • Lucas C. Mendez

   Gynecologic Cancers (LA Cantrell, Section Editor) 12 June 2020 Article: 58

   

4. Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults

   • Anand A. Patel
   • Joseph Thomas
   • Wendy Stock

   Leukemia (PH Wiernik, Section Editor) 28 May 2020 Article: 57

   

5. Defining Which Patients Are at High Risk for Recurrence of Soft Tissue Sarcoma

   • Gaya Spolverato
   • Dario Callegaro
   • Alessandro Gronchi

   Sarcoma (SH Okuno, Section Editor) 27 May 2020 Article: 56

   

6. Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates

   • Sheima Farag
   • Myles J. Smith
   • Robin L. Jones

   Sarcoma (SH Okuno, Section Editor) Open access 27 May 2020 Article: 55

   

7. Management of the Axilla after Neoadjuvant Systemic Therapy

   • Trista J. Stankowski-Drengler
   • Heather B. Neuman

   Breast Cancer (WJ Gradishar, Section Editor) 27 May 2020 Article: 54

8. Exercise Training for Cancer Survivors

   • Calvin K.W. Tong
   • Benny Lau
   • Margot K. Davis

   Cardio-oncology (MG Fradley, Section Editor) 27 May 2020 Article: 53